Nivolumab (nivo) ± ipilimumab (ipi) in advanced small-cell lung cancer (SCLC): First report of a randomized expansion cohort from CheckMate 032 - Hellmann, M D; Ott, P A; Zugazagoitia, J (J Clin Oncol, 2017)